CDK4/6 inhibitor as a novel therapeutic approach for advanced bladder cancer independently of RB1 status

  1. Rubio, C.
  2. Martínez-Fernandez, M.
  3. Segovia, C.
  4. Lodewijk, I.
  5. Suarez-Cabrera, C.
  6. Segrelles, C.
  7. Lopez-Calder, F.
  8. Munera-Maravilla, E.
  9. Santos, M.
  10. Bernardini, A.
  11. García-Escudero, R.
  12. Lorz, C.
  13. Gomez-Rodriguez, M.J.
  14. de Velasco, G.
  15. Otero, I.
  16. Villacampa, F.
  17. Guerrero-Ramos, F.
  18. Ruiz, S.
  19. de la Rosa, F.
  20. Domínguez-Rodríguez, S.
  21. Real, F.X.
  22. Malats, N.
  23. Castellano, D.
  24. Dueñas, M.
  25. Paramio, J.M.
Revue:
Clinical Cancer Research

ISSN: 1557-3265 1078-0432

Année de publication: 2019

Volumen: 25

Número: 1

Pages: 390-402

Type: Article

DOI: 10.1158/1078-0432.CCR-18-0685 GOOGLE SCHOLAR

Objectifs de Développement Durable